This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. Social medias position in pharmaceuticalresearch is further cemented by peoples growing usage of it. The expectations of customers are evolving.
The paper was presented at the International Conference on PharmaceuticalResearch and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. However, they face increasing competition from foreign generic drug suppliers, which have established themselves in the market for public tenders.
Compensation and benefits Competitive payout but may be lower than experienced representatives : At entry-level positions, you’re generally offered a base salary, but sales incentives structures may also be implemented, which (unfortunately) can limit earning potential based on performance.
” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the PharmaceuticalResearch and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone.
The UK also faces similar regulatory challenges as some public health officials and drug regulators are slow to collaborate with pharmaceuticalresearchers on aging-related work. We need to act decisively now and start to do the research really diligently.”
Pharmaceuticalresearch has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. Regulatory changes The ABPI spokesperson adds that the UK is seeing some changes towards more innovative approaches to regulation.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content